Published Year: 2021
Global Radiofrequency-Based Devices Market: Analysis and Forecast, 2021-2030
The global market for radiofrequency-based devices is predicted to grow at a CAGR of 12.81%...
Market Research Report
A quick peek into the report
Table of Contents
1.1 Global Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion and Exclusion Criteria
1.1.3 Key Findings
1.1.4 Assumptions and Limitations
1.1.5 Global Market Scenario
1.1.5.1 Realistic Scenario
1.1.5.2 Optimistic Scenario
1.1.5.3 Pessimistic Scenario
1.2 Industry Outlook
1.2.1 Technology Landscape
1.2.1.1 Key Trends
1.2.1.2 Opportunity Assessment
1.2.1.2.1 Short-Term Potential
1.2.1.2.2 Long-Term Potential
1.2.2 Patent Analysis
1.2.2.1 Patent Publication Growth Trend
1.2.2.2 Patent Analysis by Country/Cluster
1.2.3 Product Benchmarking
1.2.4 Ongoing Clinical Trial Studies
1.3 Impact of COVID-19 on Global ENT Devices Market
1.3.1 Impact on Facilities
1.3.2 Impact on Device Adoption
1.3.3 Impact on Market Size
1.3.3.1 Pre-COVID-19 Phase
1.3.3.2 During COVID-19 Phase
1.3.3.3 Post-COVID-19 Phase
1.4 Procedure Volume
1.5 Market Analysis
1.5.1 Exoscopes Market
1.5.1.1 Market Size and Forecast
1.5.1.2 By Region
1.5.1.3 By Application
1.5.1.4 By ENT Procedures
1.5.2 Comparative Analysis
1.5.2.1 Headlight Market Vs. Surgical Loop Market
1.5.2.2 Endoscopic Ear Surgeries Vs. Open Surgeries
1.5.2.2.1 Procedure Volume
1.5.2.2.2 Market Size
1.6 Business Dynamics
1.6.1 Impact Analysis
1.6.2 Business Drivers
1.6.2.1 Growing Prevalence of Hearing Disorders
1.6.2.2 Growing Technology Integration in ENT Devices
1.6.2.3 Growing Preference for Minimally Invasive Procedures in ENT Specialty
1.6.3 Business Restraints
1.6.3.1 High Cost of ENT Procedures
1.6.3.2 Social Stigma Associated with Hearing Disorders
1.6.4 Business Opportunities
1.6.4.1 Emergence of Regional ENT Device Manufacturers
1.6.4.2 Synergies Between Local Healthcare Authorities and Key Medical Device Companies
2.1 Global ENT Devices Market (by Procedure)
2.1.1 Flexible Transoral and Transnasal Procedures
2.1.1.1 Diagnosis
2.1.1.1.1 Procedure Volume
2.1.1.1.1.1 Transnasal Laryngeal Biopsies
2.1.1.1.1.2 Transnasal Injections for Vocal Cords
2.1.1.1.1.3 Transoral Flexible Diagnostic Endoscopy
2.1.1.1.2 Market Size and Forecast
2.1.1.1.2.1 Single-Use Video Endoscopes
2.1.1.1.2.2 Others
2.1.1.2 Intervention
2.1.1.2.1 Procedure Volume
2.1.1.2.1.1 Therapeutic Endoscopy of Larynx
2.1.1.2.2 Market Size and Forecast
2.1.1.2.2.1 Single-Use Video Endoscopes
2.1.1.2.2.2 Others
2.1.2 Turbinate Reduction and Endoscopic Polyp Removal
2.1.2.1 Procedure Volume
2.1.2.1.1 Turbinate Reduction
2.1.2.1.2 Endoscopic Polyp Removal
2.1.2.2 Market Size
2.1.2.2.1 Turbinate Reduction
2.1.2.2.2 Endoscopic Polyp Removal
2.1.3 Tympanostomies and Vent Tube Operations
2.1.3.1 Procedure Volume
2.1.3.2 Market Size (by Country)
2.2 Global ENT Devices Market (by End User)
2.2.1 Opportunity Assessment
2.2.2 Growth-Share Matrix
2.2.2.1 Global ENT Surgical Devices Market, Growth-Share Matrix (by End User)
2.2.2.2 Global ENT Diagnostic Devices Market, Growth Share Matrix (by End Users)
2.2.3 Hospitals
2.2.4 ENT Clinics
2.2.5 Ambulatory Centers
2.2.6 Others
3.1 Global ENT Devices Market (by Product Type)
3.1.1 Opportunity Assessment
3.1.2 Growth Share Matrix
3.1.3 Diagnostic Devices
3.1.4 Surgical Devices
3.1.5 Hearing Aids
3.1.6 Visualization Devices
3.1.6.1 By Region
3.1.7 Surgical Shavers and Debriders
3.1.7.1 By Region
3.1.8 Others
4.1 North America ENT Devices Market
4.1.1 Regulatory Framework
4.1.2 Market
4.1.2.1 Key Findings and Opportunity Assessment
4.1.2.2 Business Drivers
4.1.2.3 Business Restraints
4.1.2.4 Impact Analysis
4.1.2.5 Sizing and Forecast
4.1.3 Application
4.1.3.1 North America ENT Surgical Devices Market (by End User)
4.1.3.2 North America ENT Diagnostic Devices Market (by End User)
4.1.4 Product
4.1.4.1 North America ENT Devices Market (by Product Type)
4.1.5 North America ENT Devices Market (by Country)
4.1.5.1 U.S.
4.1.5.1.1 Market
4.1.5.1.1.1 Business Restraints
4.1.5.1.1.2 Business Drivers
4.1.5.1.1.3 Sizing and Forecast Analysis
4.1.5.1.2 Application
4.1.5.1.2.1 U.S. ENT Surgical Devices Market (by End User)
4.1.5.1.2.2 U.S. ENT Diagnostic Devices Market (by End User)
4.1.5.1.3 Product
4.1.5.1.3.1 U.S. ENT Devices Market (by Product Type)
4.1.5.2 Canada
4.1.5.2.1 Market
4.1.5.2.1.1 Business Restraints
4.1.5.2.1.2 Business Drivers
4.1.5.2.1.3 Sizing and Forecast Analysis
4.1.5.2.2 Application
4.1.5.2.2.1 Canada ENT Surgical Devices Market (by End User)
4.1.5.2.2.2 Canada ENT Diagnostic Devices Market (by End User)
4.1.5.2.3 Product
4.1.5.2.3.1 Canada ENT Devices Market (by Product Type)
4.2 Europe ENT Devices Market
4.2.1 Regulatory Framework
4.2.2 Market
4.2.2.1 Key Findings and Opportunity Assessment
4.2.2.2 Business Drivers
4.2.2.3 Business Restraints
4.2.2.4 Impact Analysis
4.2.2.5 Sizing and Forecast
4.2.3 Application
4.2.3.1 Europe ENT Surgical Devices Market (by End User)
4.2.3.2 Europe ENT Diagnostic Devices Market (by End User)
4.2.4 Product
4.2.4.1 Europe ENT Devices Market (by Product Type)
4.2.5 Europe ENT Devices Market (by Country)
4.2.5.1 Germany
4.2.5.1.1 Market
4.2.5.1.1.1 Business Restraints
4.2.5.1.1.2 Business Drivers
4.2.5.1.1.3 Sizing and Forecast Analysis
4.2.5.1.2 Application
4.2.5.1.2.1 Germany ENT Surgical Devices Market (by End User)
4.2.5.1.2.2 Germany ENT Diagnostic Devices Market (by End User)
4.2.5.1.3 Product
4.2.5.1.3.1 Germany ENT Devices Market (by Product Type)
4.2.5.2 U.K.
4.2.5.2.1 Market
4.2.5.2.1.1 Business Restraints
4.2.5.2.1.2 Business Drivers
4.2.5.2.1.3 Sizing and Forecast Analysis
4.2.5.2.2 Application
4.2.5.2.2.1 U.K. ENT Surgical Devices Market (by End User)
4.2.5.2.2.2 U.K. ENT Diagnostic Devices Market (by End User)
4.2.5.2.3 Product
4.2.5.2.3.1 U.K. ENT Devices Market (by Product Type)
4.2.5.3 France
4.2.5.3.1 Market
4.2.5.3.1.1 Business Restraints
4.2.5.3.1.2 Business Drivers
4.2.5.3.1.3 Sizing and Forecast Analysis
4.2.5.3.2 Application
4.2.5.3.2.1 France ENT Surgical Devices Market (by End User)
4.2.5.3.2.2 France ENT Diagnostic Devices Market (by End User)
4.2.5.3.3 Product
4.2.5.3.3.1 France ENT Devices Market (by Product Type)
4.2.5.4 Italy
4.2.5.4.1 Market
4.2.5.4.1.1 Business Restraints
4.2.5.4.1.2 Business Drivers
4.2.5.4.1.3 Sizing and Forecast Analysis
4.2.5.4.2 Application
4.2.5.4.2.1 Italy ENT Surgical Devices Market (by End User)
4.2.5.4.2.2 Italy ENT Diagnostic Devices Market (by End User)
4.2.5.4.3 Product
4.2.5.4.3.1 Italy ENT Devices Market (by Product Type)
4.2.5.5 Rest-of-Europe
4.2.5.5.1 Market
4.2.5.5.1.1 Business Restraints
4.2.5.5.1.2 Business Drivers
4.2.5.5.1.3 Sizing and Forecast Analysis
4.2.5.5.2 Application
4.2.5.5.2.1 Rest-of-Europe ENT Surgical Devices Market (by End User)
4.2.5.5.2.2 Rest-of-Europe ENT Diagnostic Devices Market (by End User)
4.2.5.5.3 Product
4.2.5.5.3.1 Rest-of-Europe ENT Devices Market (by Product Type)
4.3 Asia-Pacific ENT Devices Market
4.3.1 Regulatory Framework
4.3.2 Market
4.3.2.1 Key Findings and Opportunity Assessment
4.3.2.2 Business Drivers
4.3.2.3 Business Restraints
4.3.2.4 Impact Analysis
4.3.2.5 Sizing and Forecast
4.3.3 Application
4.3.3.1 Asia-Pacific ENT Surgical Devices Market (by End User)
4.3.3.2 Asia-Pacific ENT Diagnostic Devices Market (by End User)
4.3.4 Product
4.3.4.1 Asia-Pacific ENT Devices Market (by Product Type)
4.3.5 Asia-Pacific ENT Devices Market (by Country)
4.3.5.1 China
4.3.5.1.1 Market
4.3.5.1.1.1 Business Restraints
4.3.5.1.1.2 Business Drivers
4.3.5.1.1.3 Sizing and Forecast Analysis
4.3.5.1.2 Application
4.3.5.1.2.1 China ENT Surgical Devices Market (by End User)
4.3.5.1.2.2 China ENT Diagnostic Devices Market (by End User)
4.3.5.1.3 Product
4.3.5.1.3.1 China ENT Devices Market (by Product Type)
4.3.5.2 Japan
4.3.5.2.1 Market
4.3.5.2.1.1 Business Restraints
4.3.5.2.1.2 Business Drivers
4.3.5.2.1.3 Sizing and Forecast Analysis
4.3.5.2.2 Application
4.3.5.2.2.1 Japan ENT Surgical Devices Market (by End User)
4.3.5.2.2.2 Japan ENT Diagnostic Devices Market (by End User)
4.3.5.2.3 Product
4.3.5.2.3.1 Japan ENT Devices Market (by Product Type)
4.3.5.3 India
4.3.5.3.1 Market
4.3.5.3.1.1 Business Restraints
4.3.5.3.1.2 Business Drivers
4.3.5.3.1.3 Sizing and Forecast Analysis
4.3.5.3.2 Application
4.3.5.3.2.1 India ENT Surgical Devices Market (by End User)
4.3.5.3.2.2 India ENT Diagnostic Devices Market (by End User)
4.3.5.3.3 Product
4.3.5.3.3.1 India ENT Devices Market (by Product Type)
4.3.5.4 Australia
4.3.5.4.1 Market
4.3.5.4.1.1 Business Restraints
4.3.5.4.1.2 Business Drivers
4.3.5.4.1.3 Sizing and Forecast Analysis
4.3.5.4.2 Application
4.3.5.4.2.1 Australia ENT Surgical Devices Market (by End User)
4.3.5.4.2.2 Australia ENT Diagnostic Devices Market (by End User)
4.3.5.4.3 Product
4.3.5.4.3.1 Australia ENT Devices Market (by Product Type)
4.3.5.5 Rest-of-Asia-Pacific
4.3.5.5.1 Market
4.3.5.5.1.1 Business Restraints
4.3.5.5.1.2 Business Drivers
4.3.5.5.1.3 Sizing and Forecast Analysis
4.3.5.5.2 Application
4.3.5.5.2.1 Rest-of-Asia-Pacific ENT Surgical Devices Market (by End User)
4.3.5.5.2.2 Rest-of-Asia-Pacific ENT Diagnostic Devices Market (by End User)
4.3.5.5.3 Product
4.3.5.5.3.1 Rest-of-Asia-Pacific ENT Devices Market (by Product Type)
4.4 Rest-of-the-World ENT Devices Market
4.4.1 Regulatory Framework
4.4.2 Market
4.4.2.1 Key Findings and Opportunity Assessment
4.4.2.2 Business Drivers
4.4.2.3 Business Restraints
4.4.2.4 Impact Analysis
4.4.2.5 Sizing and Forecast
4.4.3 Application
4.4.3.1 Rest-of-the-World ENT Surgical Devices Market (by End User)
4.4.3.2 Rest-of-the-World ENT Diagnostic Devices Market (by End User)
4.4.4 Product
4.4.4.1 Rest-of-the-World ENT Devices Market (by Product Type)
4.4.5 Rest-of-the-World ENT Devices Market (by Region)
4.4.5.1 Latin America
4.4.5.1.1 Market
4.4.5.1.1.1 Business Restraints
4.4.5.1.1.2 Business Drivers
4.4.5.1.1.3 Sizing and Forecast Analysis
4.4.5.1.2 Application
4.4.5.1.2.1 Latin America ENT Surgical Devices Market (by End User)
4.4.5.1.2.2 Latin America ENT Diagnostic Devices Market (by End User)
4.4.5.1.3 Product
4.4.5.1.3.1 Latin America ENT Devices Market (by Product Type)
4.4.5.2 Middle East and Africa
4.4.5.2.1 Market
4.4.5.2.1.1 Business Restraints
4.4.5.2.1.2 Business Drivers
4.4.5.2.1.3 Sizing and Forecast Analysis
4.4.5.2.2 Application
4.4.5.2.2.1 Middle East and Africa ENT Surgical Devices Market (by End User)
4.4.5.2.2.2 Middle East and Africa ENT Diagnostic Devices Market (by End User)
4.4.5.2.3 Product
4.4.5.2.3.1 Middle East and Africa ENT Devices Market (by Product Type)
5.1 Competitive Benchmarking and Company Profiles
5.1.1 Competitive Landscape
5.1.1.1 Key Strategies and Developments
5.1.1.1.1 New Offerings
5.1.1.1.2 Partnerships, Alliances, and Business Expansion
5.1.1.1.3 Regulatory and Legal
5.1.1.1.4 Mergers and Acquisitions
5.1.1.1.5 Funding
5.2 Company Profiles
5.2.1 Ambu A/S
5.2.1.1 Company Overview
5.2.1.2 Role of Ambu A/S in Global ENT Devices Market
5.2.1.3 Financials
5.2.1.4 Recent Developments
5.2.1.5 SWOT Analysis
5.2.2 Atos Medical Ab
5.2.2.1 Company Overview
5.2.2.2 Role of Atos Medical Ab in the Global ENT Devices Market
5.2.2.3 Financials
5.2.2.4 Recent Developments
5.2.2.5 SWOT Analysis
5.2.3 Boston Scientific Corporation
5.2.3.1 Company Overview
5.2.3.2 Role of Boston Scientific Corporation in the Global ENT Devices Market
5.2.3.3 Financials
5.2.3.4 Recent Developments
5.2.3.5 SWOT Analysis
5.2.4 Cochlear Limited
5.2.4.1 Company Overview
5.2.4.2 Role of Cochlear Limited in the Global ENT Devices Market
5.2.4.3 Financials
5.2.4.4 Recent Developments
5.2.4.5 SWOT Analysis
5.2.5 Demant A/S
5.2.5.1 Company Overview
5.2.5.2 Role of Demant A/S in Global ENT Devices Market
5.2.5.3 Financials
5.2.5.4 Recent Developments
5.2.5.5 SWOT Analysis
5.2.6 Eckert & Ziegler BEBIG AG
5.2.6.1 Company Overview
5.2.6.2 Role of Eckert & Ziegler BEBIG AG in the Global ENT Devices Market
5.2.6.3 Financials
5.2.6.4 Recent Developments
5.2.6.5 SWOT Analysis
5.2.7 HOYA Corporation
5.2.7.1 Company Overview
5.2.7.2 Role of HOYA Corporation in Global ENT Devices Market
5.2.7.3 Financials
5.2.7.4 Recent Developments
5.2.7.5 SWOT Analysis
5.2.8 Johnson & Johnson
5.2.8.1 Company Overview
5.2.8.2 Role of Johnson & Johnson in the Global ENT Devices Market
5.2.8.3 Financials
5.2.8.4 Recent Developments
5.2.8.5 SWOT Analysis
5.2.9 KARL STORZ SE & Co. KG
5.2.9.1 Company Overview
5.2.9.2 Role of KARL STORZ SE & Co. KG in Global ENT Devices Market
5.2.9.3 Recent Developments
5.2.9.4 SWOT Analysis
5.2.10 Medtronic plc
5.2.10.1 Company Overview
5.2.10.2 Role of Medtronic plc in the Global ENT Devices Market
5.2.10.3 Financials
5.2.10.4 Recent Developments
5.2.10.5 SWOT Analysis
5.2.11 Olympus Corporation
5.2.11.1 Company Overview
5.2.11.2 Role of Olympus Corporation in Global ENT Devices Market
5.2.11.3 Financials
5.2.11.4 Recent Developments
5.2.11.5 SWOT Analysis
5.2.12 Richard Wolf GmbH
5.2.12.1 Company Overview
5.2.12.2 Role of Richard Wolf GmbH in Global ENT Devices Market
5.2.12.3 SWOT Analysis
5.2.13 Smith & Nephew Plc
5.2.13.1 Company Overview
5.2.13.2 Role of Smith & Nephew Plc in Global ENT Devices Market
5.2.13.3 Financials
5.2.13.4 Recent Developments
5.2.13.5 SWOT Analysis
5.2.14 Sonova Holding AG
5.2.14.1 Company Overview
5.2.14.2 Role of Sonova Holding AG in Global ENT Devices Market
5.2.14.3 Financials
5.2.14.4 Recent Developments
5.2.14.5 SWOT Analysis
5.2.15 Stryker Corporation
5.2.15.1 Company Overview
5.2.15.2 Role of Stryker Corporation in Global ENT Devices Market
5.2.15.3 Financials
5.2.15.4 Recent Developments
5.2.15.5 SWOT Analysis
6.1 Data Collection and Analysis
6.2 Data Sources
6.2.1 Primary Sources
6.2.2 Secondary Sources
6.3 Data Triangulation
6.4 Market Estimation
6.5 Assumptions and Limitations
Table 1: Global ENT Devices Market, Impact Analysis
Table 2: Global ENT Devices Market, Inclusion Criteria
Table 3: Global ENT Devices Market, Exclusion Criteria
Table 4: Global ENT Devices Market, Key Trends
Table 5: Global ENT Devices Market, Product Benchmarking
Table 6: Global ENT Devices Market, Ongoing Clinical Trials
Table 7: Global ENT Devices Market, Key Procedure Volumes, 2016-2019
Table 8: Comparative Analysis Between Headlight Market and Surgical Loop Market
Table 9: ENT Procedures Share, by Modality, 2019
Table 10: Global ENT Devices Market, Impact Analysis
Table 11: FDA Approved/Cleared Advanced ENT Devices, 2019
Table 12: North America ENT Devices Market Regulatory Framework
Table 13: North America ENT Devices Market, Impact Analysis
Table 14: Challenges in MDR Implementation
Table 15: Europe ENT Devices Market, Impact Analysis
Table 16: Asia-Pacific ENT Devices Market Regulatory Framework
Table 17: Asia-Pacific ENT Devices Market, Impact Analysis
Table 18: Rest-of-the-World ENT Devices Market Regulatory Framework
Table 19: Rest-of-the-World ENT Devices Market, Impact Analysis
Figure 1: Global ENT Devices Market, $Million, 2020-2030
Figure 2: Global ENT Devices Market, Industry Analysis
Figure 3: Global ENT Devices Market, Key Developments, January 2018-15th November 2021
Figure 4: Global ENT Devices Market Share Analysis (by Product), 2020 Vs. 2030
Figure 5: Global ENT Devices Market (by Region), 2020 and 2030
Figure 6: Global ENT Devices Market, Realistic Growth Scenario, $Million, 2020-2030
Figure 7: Global ENT Devices Market, Optimistic Growth Scenario, $Million, 2020-2030
Figure 8: Global ENT Devices Market, Pessimistic Growth Scenario, $Million, 2020-2030
Figure 9: Global ENT Devices Market, Short-Term Potential, $Million, 2020-2025
Figure 10: Global ENT Devices Market, Long-Term Growth, $Million, 2025-2030
Figure 11: Global ENT Devices Market, Patent Filing Trend (by Year), 2016-2021
Figure 12: Global ENT Devices Market, Patent Filing Trend (by Country/Cluster), 2016-2021
Figure 13: Global Exoscopes Market, $Million, 2020-2030
Figure 14: Global Exoscopes Market (by Region), $Million, 2020-2030
Figure 15: Global Exoscopes Market (by Application), $Million, 2020-2030
Figure 16: Global ENT Exoscopes Market (by Application), $Million, 2020-2030
Figure 17: Global Endoscopic and Visualization Market, $Million, 2020-2030
Figure 18: Global Prevalence of Hearing Loss, 2015-2019
Figure 19: Prevalence of Disabling Hearing Loss, 2018
Figure 20: Global ENT Devices Market, by Procedure
Figure 21: Diagnostic Endoscopy of Larynx Procedure Volume, 2019-2020
Figure 22: Transnasal Laryngeal Biopsies Procedure Volume, 2019-2020
Figure 23: Transnasal Injections for Vocal Cords Procedure Volume, 2019-2020
Figure 24: Transnasal Flexible Diagnostic Endoscopy Procedure Volume, 2019-2020
Figure 25: Global ENT Diagnostic Devices Market (Single-Use Video Endoscopes), $Million, 2020-2030
Figure 26: Global ENT Diagnostic Devices Market (by Others), $Million, 2020-2030
Figure 27: Therapeutic Endoscopy of Larynx Procedure Volume, 2019-2020
Figure 28: Global ENT Intervention Devices Market (Single-Use Video Endoscopes), $Million, 2020-2030
Figure 29: Global ENT Intervention Devices Market (by Others), $Million, 2020-2030
Figure 30: Turbinate Reduction Procedure Volume, 2019-2020
Figure 31: Endoscopic Polyp Removal Procedure Volume, 2019-2020
Figure 32: Global Turbinate Reduction Market, $Million, 2019-2020
Figure 33: Global Endoscopic Polyp Removal Market, $Million, 2019-2020
Figure 34: Tympanostomies and Vent Tube Operations Procedure Volume, 2019-2020
Figure 35: Tympanostomies and Vent Tube Operations Market, $Million, 2019-2020
Figure 36: Global ENT Devices Market (by End User)
Figure 37: Global ENT Surgical Devices Market, Growth Share Matrix (by End User), 2020-2030
Figure 38: Global ENT Diagnostic Devices Market, Growth Share Matrix (by End User), 2020-2030
Figure 39: Global ENT Surgical Devices Market (by Hospitals), $Million, 2020-2030
Figure 40: Global ENT Diagnostic Devices Market (by Hospitals), $Million, 2020-2030
Figure 41: Global ENT Surgical Devices Market (by ENT Clinics), $Million, 2020-2030
Figure 42: Global ENT Diagnostic Devices Market (by ENT Clinics), $Million, 2020-2030
Figure 43: Global ENT Surgical Devices Market (by Ambulatory Centers), $Million, 2020-2030
Figure 44: Global ENT Diagnostic Devices Market (by Ambulatory Centers), $Million, 2020-2030
Figure 45: Global ENT Diagnostic Devices Market (by Others), $Million, 2020-2030
Figure 46: Global ENT Devices Market Incremental Growth Opportunity (by Product Type), $Million, 2020-2030
Figure 47: Global ENT Devices Market, Growth Share Matrix (by Product Type), 2020-2030
Figure 48: Global ENT Devices Market (Diagnostic Devices), $Million, 2020-2030
Figure 49: Global ENT Devices Market (Surgical Devices), $Million, 2020-2030
Figure 50: Global ENT Devices Market (Hearing Aids), $Million, 2020-2030
Figure 51: Global ENT Devices Market (Visualization Devices), $Million, 2020-2030
Figure 52: Global ENT Visualization Devices Market (by Region), $Million, 2020-2030
Figure 53: Global ENT Devices Market (Surgical Shavers and Debriders), $Million, 2020-2030
Figure 54: Global ENT Surgical Shavers and Debriders Market (by Region), $Million, 2020-2030
Figure 55: Global ENT Devices Market (by Others), $Million, 2020-2030
Figure 56: Global ENT Devices Market (by Region), 2020 and 2030
Figure 57: North America ENT Devices Market Incremental Growth Opportunity, $Million, 2020-2030
Figure 58: North America ENT Devices Market, $Million, 2020-2030
Figure 59: North America ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 60: North America ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 61: North America ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 62: U.S. ENT Devices Market, $Million, 2020-2030
Figure 63: U.S. ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 64: U.S. ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 65: U.S. ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 66: Canada ENT Devices Market, $Million, 2020-2030
Figure 67: Canada ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 68: Canada ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 69: Canada ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 70: Europe ENT Devices Market Incremental Growth Opportunity, $Million, 2020-2030
Figure 71: Europe ENT Devices Market, $Million, 2020-2030
Figure 72: Europe ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 73: Europe ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 74: Europe ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 75: Germany ENT Devices Market, $Million, 2020-2030
Figure 76: Germany ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 77: Germany ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 78: Germany ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 79: U.K. ENT Devices Market, $Million, 2020-2030
Figure 80: U.K. ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 81: U.K. ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 82: U.K. ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 83: France ENT Devices Market, $Million, 2020-2030
Figure 84: France ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 85: France ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 86: France ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 87: Italy ENT Devices Market, $Million, 2020-2030
Figure 88: Italy ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 89: Italy ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 90: Italy ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 91: Rest-of-Europe ENT Devices Market, $Million, 2020-2030
Figure 92: Rest-of-Europe ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 93: Rest-of-Europe ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 94: Rest-of-Europe ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 95: Asia-Pacific ENT Devices Market Incremental Growth Opportunity, $Million, 2020-2030
Figure 96: Asia-Pacific ENT Devices Market, $Million, 2020-2030
Figure 97: Asia-Pacific ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 98: Asia-Pacific ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 99: Asia-Pacific ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 100: China ENT Devices Market, $Million, 2020-2030
Figure 101: China ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 102: China ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 103: China ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 104: Japan ENT Devices Market, $Million, 2020-2030
Figure 105: Japan ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 106: Japan ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 107: Japan ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 108: India ENT Devices Market, $Million, 2020-2030
Figure 109: India ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 110: India ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 111: India ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 112: Australia ENT Devices Market, $Million, 2020-2030
Figure 113: Australia ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 114: Australia ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 115: Australia ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 116: Rest-of-Asia-Pacific ENT Devices Market, $Million, 2020-2030
Figure 117: Rest-of-Asia-Pacific ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 118: Rest-of-Asia-Pacific ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 119: Rest-of-Asia-Pacific ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 120: Rest-of-the-World ENT Devices Market Incremental Growth Opportunity, $Million, 2020-2030
Figure 121: Rest-of-the-World ENT Devices Market, $Million, 2020-2030
Figure 122: Rest-of-the-World ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 123: Rest-of-the-World ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 124: Rest-of-the-World ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 125: Latin America ENT Devices Market, $Million, 2020-2030
Figure 126: Latin America ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 127: Latin America ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 128: Latin America ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 129: Middle East and Africa ENT Devices Market, $Million, 2020-2030
Figure 130: Middle East and Africa ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 131: Middle East and Africa ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 132: Middle East and Africa ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 133: Share of Key Developments and Strategies, January 2018-15th November 2021
Figure 134: New Offerings Share (by Company), January 2018-15th November 2021
Figure 135: Partnerships, Alliances, and Business Expansion Share (by Company), January 2018-15th November 2021
Figure 136: Regulatory and Legal Share (by Company), January 2018-15th November 2021
Figure 137: Mergers and Acquisitions Share (by Company), January 2018-15th November 2021
Figure 138: Funding Activities Share (by Company), January 2018-15th November 2021
Figure 139: Ambu A/S: Overall Product Portfolio
Figure 140: Ambu A/S: Overall Financials, $Million, 2019-2021
Figure 141: Ambu A/S: Revenue (by Business Segment), $Million, 2019-2021
Figure 142: Ambu A/S: Revenue (by Region), $Million, 2019-2021
Figure 143: Ambu A/S: R&D Expenditure, $Million, 2019-2021
Figure 144: Atos Medical Ab: Overall Product Portfolio
Figure 145: Atos Medical Ab: Overall Financials, $Million, 2018-2020
Figure 146: Atos Medical Ab: Revenue (by Business Segment), $Million, 2018-2020
Figure 147: Atos Medical Ab: Revenue (by Region), $Million, 2019-2020
Figure 148: Atos Medical Ab: Revenue (by Region), $Million, 2018
Figure 149: Atos Medical Ab: R&D Expenditure, $Million, 2018-2020
Figure 150: Boston Scientific Corporation: Overall Product Portfolio
Figure 151: Boston Scientific Corporation: Overall Financials, $Million, 2018-2020
Figure 152: Boston Scientific Corporation: Revenue (by Business Segment), $Million, 2018-2020
Figure 153: Boston Scientific Corporation: Revenue (by Region), $Million, 2018-2020
Figure 154: Boston Scientific Corporation: R&D Expenditure, $Million, 2018-2020
Figure 155: Cochlear Limited: Overall Product Portfolio
Figure 156: Cochlear Limited: Overall Financials, $Million, 2019-2021
Figure 157: Cochlear Limited: Revenue (by Business Segment), $Million, 2019-2021
Figure 158: Cochlear Limited: Revenue (by Region), $Million, 2019-2021
Figure 159: Cochlear Limited: R&D Expenditure, $Million, 2019-2021
Figure 160: Demant A/S: Overall Product Portfolio
Figure 161: Demant A/S: Overall Financials, $Million, 2018-2020
Figure 162: Demant A/S: Revenue (by Business Segment), $Million, 2018-2020
Figure 163: Demant A/S: Revenue (by Region), $Million, 2018-2020
Figure 164: Demant A/S: R&D Expenditure, $Million, 2018-2020
Figure 165: Eckert & Ziegler BEBIG AG: Overall Product Portfolio
Figure 166: Eckert & Ziegler BEBIG AG:Overall Financials, $Million, 2018-2020
Figure 167: Eckert & Ziegler BEBIG AG: Revenue (by Business Segment), $Million, 2018
Figure 168: Eckert & Ziegler BEBIG AG: Revenue (by Business Segment), $Million, 2019-2020
Figure 169: Eckert & Ziegler BEBIG AG: Revenue (by Region), $Million, 2018-2020
Figure 170: Eckert & Ziegler BEBIG AG: R&D Expenditure, $Million, 2018-2020
Figure 171: HOYA Corporation: Overall Product Portfolio
Figure 172: HOYA Corporation: Overall Financials, $Million, 2019-2021
Figure 173: HOYA Corporation: Revenue (by Business Segment), $Million, 2019-2021
Figure 174: HOYA Corporation: Revenue (by Region), $Million, 2019-2021
Figure 175: HOYA Corporation: R&D Expenditure, $Million, 2019-2021
Figure 176: Johnson & Johnson: Overall Product Portfolio
Figure 177: Johnson & Johnson: Overall Financials, $Million, 2018-2020
Figure 178: Johnson & Johnson: Revenue (by Business Segment), $Million, 2018-2020
Figure 179: Johnson & Johnson: Revenue (by Region), $Million, 2018-2020
Figure 180: Johnson & Johnson: R&D Expenditure, $Million, 2018-2020
Figure 181: KARL STORZ SE & Co. KG: Overall Product Portfolio
Figure 182: Medtronic plc: Overall Product Portfolio
Figure 183: Medtronic plc: Overall Financials, $Million, 2019-2021
Figure 184: Medtronic plc: Revenue (by Business Segment), $Million, 2019-2021
Figure 185: Medtronic plc: Revenue (by Region), $Million, 2019-2021
Figure 186: Medtronic plc: R&D Expenditure, $Million, 2019-2021
Figure 187: Olympus Corporation: Overall Product Portfolio
Figure 188: Olympus Corporation: Overall Financials, $Million, 2019-2021
Figure 189: Olympus Corporation: Revenue (by Business Segment), $Million, 2020-2021
Figure 190: Olympus Corporation: Revenue (by Business Segment), $Million, 2019
Figure 191: Olympus Corporation: Revenue (by Region), $Million, 2020-2021
Figure 192: Olympus Corporation: Revenue (by Region), $Million, 2019
Figure 193: Olympus Corporation: R&D Expenditure, $Million, 2019-2021
Figure 194: Richard Wolf GmbH: Overall Product Portfolio
Figure 195: Smith & Nephew Plc: Overall Product Portfolio
Figure 196: Smith & Nephew Plc: Overall Financials, $Million, 2018-2020
Figure 197: Smith & Nephew Plc: Revenue (by Business Segment), $Million, 2018-2020
Figure 198: Smith & Nephew Plc: Revenue (by Region), $Million, 2018-2020
Figure 199: Smith & Nephew Plc: R&D Expenditure, $Million, 2018-2020
Figure 200: Sonova Holding AG: Overall Product Portfolio
Figure 201: Sonova Holding AG: Overall Financials, $Million, 2019-2021
Figure 202: Sonova Holding AG: Revenue (by Business Segment), $Million, 2019-2021
Figure 203: Sonova Holding AG: Revenue (by Region), $Million, 2019-2021
Figure 204: Sonova Holding AG: R&D Expenditure, $Million, 2019-2021
Figure 205: Stryker Corporation: Overall Product Portfolio
Figure 206: Stryker Corporation: Overall Financials, $Million, 2018-2020
Figure 207: Stryker Corporation: Revenue (by Business Segment), $Million, 2018-2020
Figure 208: Stryker Corporation: Revenue (by Region), $Million, 2018-2020
Figure 209: Stryker Corporation: R&D Expenditure, $Million, 2018-2020
Figure 210: Global ENT Devices Market, Research Methodology
Figure 211: Primary Research
Figure 212: Secondary Research
Figure 213: Data Triangulation
Figure 214: Assumptions and Limitations
Market Report Coverage
|
ENT Devices Market |
|||
|
Base Year |
2020 |
Market Size in 2021 |
$14,728.5 Million |
|
Forecast Period |
2021-2030 |
Value Projection and Estimation by 2030 |
$25,127.7 Million |
|
CAGR During Forecast Period |
6.12% |
Number of Tables |
19 |
|
Number of Pages |
233 |
Number of Figures |
214 |
|
Market Segmentation |
• Procedure Type - Flexible Transoral and Transnasal Procedures (Diagnosis and Intervention), Turbinate Reduction and Endoscopic Polyp Removal, and Tympanostomies and Vent Tube Operations • End User - Hospitals, ENT Clinics, Ambulatory Centers, and Others • Product Type - Diagnostic Devices, Surgical Devices, Hearing Aids, Visualization Devices, Surgical Shavers and Debriders, and Others |
||
|
Regional Segmentation |
• North America - U.S. and Canada • Europe - Germany, U.K., France, Italy, and Rest-of-Europe • Asia-Pacific - Japan, China, India, Australia, and Rest-of-Asia-Pacific • Rest-of-the-World - Latin America and Middle East and Africa |
||
|
Market Growth Drivers |
• Growing Prevalence of Hearing Disorders • Growing Technology Integration in ENT Devices • Growing Preference for Minimally Invasive Procedures in ENT Specialty |
||
|
Market Challenges |
• High Cost of ENT Procedures • Social Stigma Associated with Hearing Disorders |
||
|
Market Opportunities |
• Emergence of Regional ENT Device Manufacturers • Synergies Between Local Healthcare Authorities and Key Medical Device Companies |
||
|
Key Companies Profiled |
Ambu A/S, Atos Medical Ab, Boston Scientific Corporation, Cochlear Limited, Demant A/S, Eckert & Ziegler BEBIG AG, HOYA Corporation, Johnson & Johnson, KARL STORZ SE & Co. KG, Medtronic plc, Olympus Corporation, Richard Wolf GmbH, Smith & Nephew Plc, Sonova Holding AG, Stryker Corporation |
||
How This Report Can Add Value
Assuming that the readers are the manufacturers of ENT devices market, they will be able to do the following:
• Understand their position compared to some of the key players in the market
• Stay updated with novel technology integration, features, and the latest developments in the market
• Understand the impact of COVID-19 on the adoption of ENT devices and the entry barriers because of it
• Gain insights into end-user perception with respect to the adoption of ENT
• Identify some of the key players in the market and understand their valuable contribution
Key Questions Answered in the Global ENT Devices Market Report
• What are the key trends that have a strong influence on the global ENT devices market? How did the COVID-19 pandemic impact the growth of the ENT devices market?
• What are the key development strategies which are implemented by the key players to maintain and capture market share?
• How does the patent landscape of ENT devices look like?
• What are the major market drivers, challenges, and opportunities in the global ENT devices market?
• Which leading companies are dominating the global ENT devices market?
• What are the regulations about the global ENT devices market?
• What was the market value of the leading segments and sub-segments of the global ENT devices market?
• How is each segment of the global ENT devices market expected to grow during the forecast period, and what is the expected revenue to be generated by each of the segment by the end of 2030?
• Which region carries the potential for the significant expansion of key companies for the ENT devices market?
Report Summary
Global ENT Devices Market Industry Overview
ENT devices are used for diagnosing and treating various disorders of the ear, nose, and throat. The devices can be classified into diagnostic devices, surgical devices, visualization devices, hearing aids, surgical shavers and debriders, and others.
The global ENT devices market is witnessing a high degree of technology integration over the past years. The market comprises various key medical device companies and local companies. The major factors that have a positive impact on the market’s growth include the growing prevalence of hearing disorders, growing technology integration in ENT devices, and growing preference for minimally invasive procedures in ENT specialty.
During COVID-19, the growth of the ENT devices market was negatively impacted, especially in 2020. Although the market recovered quickly in the last quarter of 2020 and the telehealth integration in ENT specialty was a positive impact of COVID-19 on the market.
The global ENT devices market report highlights that the market was valued at $13,799.5 million in 2020 and is expected to reach $25,127.7 million by the end of 2030. The market is expected to grow at a CAGR of 6.12% during the forecast period from 2021 to 2030.
Global ENT Devices Market Drivers
The factors driving the growth of the market include the growing prevalence of hearing disorders, growing technology integration in ENT devices, and growing preference for minimally invasive procedures in the ENT specialty. The growing prevalence of hearing disorders is the major driver for the market in established and emerging economies. For instance, according to a study published in The Lancet in March 2021, titled, ‘Hearing Loss Prevalence and Years Lived with Disability, 1990–2019: Findings from The Global Burden of Disease Study 2019’, approximately 1.5 billion people suffered from hearing disability globally in 2019. This infers that one in every five people suffered from a form of hearing disability globally. Furthermore, hearing disability is the third common factor for years lived with disability (YLDs) in the global population. The prevalence of hearing loss is projected to grow over the coming decade. According to World Health Organization (WHO), the number of people suffering from disabling hearing loss (DHL) can grow up to 630 million in 2030 and over 900 million by 2050.
Consequently, the rising prevalence of hearing disorders will propel the adoption of hearing aid treatments and advance the growth of the global ENT devices market.
Global ENT Devices Market Challenges
The factors restraining the growth of the global ENT devices market include the high cost of the ENT procedures and the social stigma associated with hearing disorders. The high cost has limited the procedure volume in emerging as well as developed economies. For instance, according to a study published in NCBI in 2018, titled, ‘Health Care Costs and Cost-Effectiveness in Laryngotracheal Stenosis’, treatment of laryngotracheal stenosis (LTS) is one of the expensive ENT procedures. The mean annual cost associated with the disease was $4,080.09. Furthermore, according to another study titled, ‘Comparison of the Financial Burden of Survivors of Head and Neck Cancer with Other Cancer Survivors’, which was published in March 2019, patients getting treatment for head and neck cancer bear higher expenses as compared to other cancer patients. Also, these patients bear higher out-of-pocket costs. Thus, the high cost of the procedures and lack of reimbursement harm the growth of the global ENT devices market.
Global ENT Devices Market Opportunities
Emerging of regional ENT devices manufacturers and synergies between local healthcare authorities and key medical device companies are the major opportunities in the global ENT devices market. The key companies operating in the market can expand in emerging economies by partnering with local healthcare authorities. Such synergies will enable the companies to penetrate the markets effectively and expand their customer base. For instance, Cochlear Limited partnered with The Royal Victorian Eye and Ear Hospital in the U.K. for the development of Geelong Cochlear Care Centre. The center is the first care center of Cochlear Limited in the U.K. and is projected to improve the company’s presence in the country.
Impact of COVID-19 on the Global ENT Devices Market
During COVID-19, the growth of the ENT devices market was negatively impacted, especially in 2020. Although the ENT facilities continued to operate, the sales of the companies were negatively impacted. Nonetheless, the market grew minimally in 2020 and is projected to witness considerable growth during the forecast period 2021-2030. The increasing technological innovations in the global market and growing adoption in emerging economies are the factors for the growth of the market.
Market Segmentation
Global ENT Devices Market (by Procedure)
The global ENT devices market, on the basis of procedure, has been segmented into flexible transoral and transnasal procedures, turbinate reduction and polyp removal, and tympanostomies and vent tube operations.
The flexible transoral and transnasal procedures accounted for the highest share of the market, which can be attributed to advancements in ENT devices.
Global ENT Devices Market (by End User)
The global ENT devices market, on the basis of end users, has been segmented into hospitals, ambulatory centers, ENT clinics, and others.
Hospitals are at the forefront in terms of ENT devices adoption. The increasing focus on evidence-based care has been one of the strongest drivers for the adoption of ENT.
The growing prominence for outpatient surgeries and rising establishments of ambulatory centers are the leading factors promoting the market's growth for the global ENT devices. The adoption of ENT devices in ambulatory surgical centers can be boosted by prioritizing the increasing demand for minimally invasive surgeries.
Global ENT Devices Market (by Product Type)
The global ENT devices market, on the basis of product type, has been segmented into diagnostic devices, surgical devices, hearing aids, visualization devices, surgical shavers and debriders, and others.
Hearing aids is the largest product segment in the market, and the trend is projected to continue during the forecast period 2021-2030. Furthermore, surgical devices is projected to be the fastest-growing segment owing to the growing technological advancements in the ENT specialty.
Global ENT Devices Market (by Region)
The different regions covered under the global ENT devices market include North America, Europe, Asia-Pacific, and Rest-of-the-World.
North America dominates the global ENT devices market due to the high prevalence of hearing disorders, growing geriatric population, and high reimbursement rates. The Asia-Pacific ENT devices market is one of the lucrative markets with immense potential for expansion by key players of the global ENT market. The Asia-Pacific ENT devices market is expected to grow at the fastest rate in the forecast period, and this can be attributed to the massive geriatric population base, driving the demand for minimally invasive and non-invasive surgical procedures.
Key Market Players and Competition Synopsis
Some of the key players operating in the market include Ambu A/S, Atos Medical Ab, Boston Scientific Corporation, Cochlear Limited, Demant A/S, Eckert & Ziegler AG, HOYA Corporation, Johnson & Johnson, KARL STORZ SE & Co. KG, Medtronic plc, Olympus Corporation, Richard Wolf GmbH, Smith & Nephew Plc, Sonova Holding AG, and Stryker Corporation.
Some of the strategies covered in this segment are funding activities, mergers and acquisitions (M&As), partnerships, alliances, and business expansion, regulatory and legal activities, and new offerings. The preferred strategy for companies has been launches of new products or new offerings followed by partnerships, alliances, and business expansion.
ENT Devices Market - A Global and Regional Analysis
Focus on Procedure, End User, Product Type, and Country-Wise Analysis - Analysis and Forecast, 2021-2030
Some Faq's
Frequently Asked Questions
The global ENT devices market report highlights that the market was valued at $13,799.5 million in 2020 and is expected to reach $25,127.7 million by the end of 2030.
The top market players are Ambu A/S, Atos Medical Ab, Boston Scientific Corporation, Cochlear Limited, Demant A/S, Eckert & Ziegler BEBIG AG, HOYA Corporation, Johnson & Johnson, KARL STORZ SE & Co. KG, Medtronic plc, Olympus Corporation, Richard Wolf GmbH, Smith & Nephew Plc, Sonova Holding AG, Stryker Corporation.
Factors driving the growth of the ENT devices market are the growing prevalence of hearing disorders, growing technology integration in ENT devices, and growing preference for minimally invasive procedures in the ENT specialty.
Some of the main challenges restricting the growth of the ENT devices market are the high cost of ENT procedures and the social stigma associated with hearing disorders.
The potential opportunities that are likely to boost the growth of the ENT devices market are the emergence of regional ENT device manufacturers and synergies between local healthcare authorities and key medical device companies.
Similar Product
You may also like
Published Year: 2021
Global 4K Medical Imaging Market: Analysis and Forecast, 2020-2030
The global 4K medical imaging market was valued at $822.1 million in 2019 and is anticipated...
Published Year: 2020
Global Single-Use/Disposable Endoscopy Market: Analysis and Forecast, 2021-2030
The global single-use/disposable endoscopy market was estimated to be $471.7 million in...
Published Year: 2019
Global Next-Generation Visualization and Navigation Systems Market – Analysis and Forecast, 2019-2
The global next-generation visualization and navigation systems market was valued at $1.08...